Watchlist Price Alert

Sangamo Therapeutics Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.48

-0.02 (-4.57%)

At close: Jun 13, 2025, 3:59 PM

Sangamo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	41.92M	45.2M	100.44M	178.87M	131.33M	80.43M	140.42M	49.83M	22.06M
Short-Term Investments	n/a	35.8M	177.19M	197.68M	510.09M	282.05M	259.71M	193.48M	120.47M
Long-Term Investments	n/a	n/a	29.84M	88.17M	50.53M	21.83M	-6.71M	1.01M	n/a
Other Long-Term Assets	15.19M	18.13M	12.25M	10.17M	7.87M	4M	6.24M	4.68M	169K
Receivables	4.6M	4.07M	4.47M	6.36M	6.26M	37.59M	5.05M	3.58M	5.2M
Inventory	n/a	n/a	n/a	-88.17M	-50.53M	-22.51M	-375K	-1.25M	-224K
Other Current Assets	5.17M	9.26M	18.22M	15.86M	11.99M	5.41M	5.34M	1.51M	n/a
Total Current Assets	51.69M	94.33M	300.33M	398.77M	659.67M	405.47M	410.52M	248.4M	149.58M
Property-Plant & Equipment	34.76M	52.87M	125.53M	124.7M	112.37M	107.22M	78.72M	31.07M	6.56M
Goodwill & Intangibles	n/a	n/a	88.28M	93.46M	100.93M	92.43M	94.91M	1.58M	1.58M
Total Long-Term Assets	49.94M	70.99M	262.18M	323.15M	278.88M	232.04M	179.87M	38.34M	8.31M
Total Assets	101.64M	165.32M	562.51M	721.92M	938.55M	637.52M	590.39M	286.74M	157.89M
Account Payables	15.48M	15.26M	22.42M	9.76M	12.55M	6.67M	3.35M	16K	2.58M
Deferred Revenue	7.56M	n/a	51.78M	85.71M	96.64M	38.71M	47.56M	28.34M	4.14M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	14.57M	11.73M	11.88M	7.55M	96.64M	7.67M	9.69M	5.9M	3.38M
Total Current Liabilities	45.8M	47.73M	111.71M	127.89M	143.55M	69.87M	78.51M	44.86M	13.29M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	933K	1.19M	1.21M	1.22M	7.01M	5.71M	1.96M	n/a	n/a
Total Long-Term Liabilities	33.06M	34.7M	155.84M	218.69M	297.64M	134.91M	144.63M	53.98M	8.4M
Total Liabilities	78.86M	82.43M	267.55M	346.58M	441.18M	204.78M	223.88M	98.84M	21.7M
Total Debt	30.57M	38.1M	43.11M	48.08M	42.09M	44.41M	27.69M	24.74M	3.94M
Common Stock	2.13M	1.78M	1.67M	1.46M	1.42M	1.16M	1.02M	856K	709K
Retained Earnings	-1.5B	-1.41B	-1.15B	-956.27M	-777.98M	-656.99M	-562.7M	-495.48M	-440.91M
Comprehensive Income	-7.53M	-4.59M	-8.4M	-3.99M	5.42M	-2.45M	-1.44M	-286K	20K
Shareholders Equity	22.77M	82.89M	294.96M	375.34M	497.37M	432.74M	366.52M	187.9M	136.19M
Total Investments	n/a	35.8M	207.03M	285.85M	560.62M	303.88M	259.71M	194.49M	120.47M